PROQR THERAPEUTICS NV (PRQR:NASDAQ)
$1.79 -0.06 (-3.2432%)
Analysed PROQR THERAPEUTICS NV (PRQR:NASDAQ) News Sources
ProQR Highlights Pipeline Expansion and Multiple Upcoming Clinical Catalysts at Investor and Analyst Event
08-04-2026
yahoo.com
ProQR Therapeutics Unveils New RNA Editing Programs; AX-0810 Phase 1 Target Data Due This Quarter
08-04-2026
marketbeat.com
ProQR Announces Partnership with Ginkgo Bioworks and Formation of AI Advisory Board
08-04-2026
yahoo.com
April 2026 Penny Stock Highlights
03-04-2026
yahoo.com
Oppenheimer Predicts Up to ~560% Rally for These 2 ‘Strong Buy’ Stocks
29-03-2026
yahoo.com
Growing Optimism About ProQR Therapeutics (PRQR)’s RNA Editing Platform and Future Clinical Catalysts
25-03-2026
yahoo.com
ProQR to Host Virtual Investor and Analyst Event Highlighting Pipeline on April 8, 2026
25-03-2026
yahoo.com
ProQR (PRQR) Reports Q4 Loss, Lags Revenue Estimates
12-03-2026
yahoo.com
ProQR: Q4 Earnings Snapshot
12-03-2026
yahoo.com
ProQR Announces Year End 2025 Operating and Financial Results
12-03-2026
yahoo.com
What is the current price of PROQR THERAPEUTICS NV (PRQR:NASDAQ)?
The current price of PROQR THERAPEUTICS NV (PRQR:NASDAQ) is $1.79.
PROQR THERAPEUTICS NV (PRQR:NASDAQ) absolute price change since previous trading day?
The absolute price change of PROQR THERAPEUTICS NV (PRQR:NASDAQ) since the previous trading day is $-0.06.
PROQR THERAPEUTICS NV (PRQR:NASDAQ) percentage price change since previous trading day?
The percentage price change of PROQR THERAPEUTICS NV (PRQR:NASDAQ) since the previous trading day is -3.2432%.
What is the most recent average sentiment score for PROQR THERAPEUTICS NV (PRQR:NASDAQ)?
The most recent average sentiment score for PROQR THERAPEUTICS NV (PRQR:NASDAQ) is 75 out of 100.
What is the most recent average sentiment for PROQR THERAPEUTICS NV (PRQR:NASDAQ)?
The most recent sentiment for PROQR THERAPEUTICS NV (PRQR:NASDAQ) is .
SEC-8K** Filing Available For PROQR THERAPEUTICS NV (PRQR:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.